| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | EPHB3 EPHB4 DCAF1 TNIK MAPKAPK2 POLE NTRK2 POLR2A MINK1 RET TEP1 MAP3K4 PARP4 TAOK3 MAP4K5 MAP4K1 NRK ERVK-8 TAOK1 FGR MAP4K4 DCLK1 | 1.89e-07 | 938 | 131 | 22 | GO:0016772 |
| GeneOntologyMolecularFunction | kinase binding | TTC28 PSG1 PSG3 NBEAL1 PSG7 MAPKAPK2 PSG11 NTRK2 POLR2A NAIP GATA4 BCAR1 PDLIM5 PRR7 AP2A1 AP2A2 TAX1BP1 TAOK1 PSG8 MYOM2 PAX6 FGR | 3.29e-07 | 969 | 131 | 22 | GO:0019900 |
| GeneOntologyMolecularFunction | protein kinase activity | EPHB3 EPHB4 DCAF1 TNIK MAPKAPK2 NTRK2 MINK1 RET MAP3K4 TAOK3 MAP4K5 MAP4K1 NRK TAOK1 FGR MAP4K4 DCLK1 | 4.13e-07 | 600 | 131 | 17 | GO:0004672 |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 1.68e-06 | 14 | 131 | 4 | GO:0005130 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | EPHB3 EPHB4 DCAF1 TNIK MAPKAPK2 NTRK2 MINK1 RET MAP3K4 TAOK3 MAP4K5 MAP4K1 NRK TAOK1 FGR MAP4K4 DCLK1 | 4.01e-06 | 709 | 131 | 17 | GO:0016773 |
| GeneOntologyMolecularFunction | protein serine kinase activity | DCAF1 TNIK MAPKAPK2 MINK1 MAP3K4 TAOK3 MAP4K5 MAP4K1 NRK TAOK1 MAP4K4 DCLK1 | 4.95e-06 | 363 | 131 | 12 | GO:0106310 |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase kinase activity | 5.44e-06 | 6 | 131 | 3 | GO:0008349 | |
| GeneOntologyMolecularFunction | kinase activity | EPHB3 EPHB4 DCAF1 TNIK MAPKAPK2 NTRK2 MINK1 RET MAP3K4 TAOK3 MAP4K5 MAP4K1 NRK TAOK1 FGR MAP4K4 DCLK1 | 1.07e-05 | 764 | 131 | 17 | GO:0016301 |
| GeneOntologyMolecularFunction | GPI anchor binding | 1.42e-05 | 23 | 131 | 4 | GO:0034235 | |
| GeneOntologyMolecularFunction | protein kinase binding | PSG1 PSG3 NBEAL1 PSG7 MAPKAPK2 PSG11 NTRK2 NAIP GATA4 BCAR1 PDLIM5 PRR7 AP2A1 AP2A2 TAOK1 PSG8 PAX6 FGR | 1.62e-05 | 873 | 131 | 18 | GO:0019901 |
| GeneOntologyMolecularFunction | filamin binding | 3.70e-05 | 29 | 131 | 4 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 3.70e-05 | 29 | 131 | 4 | GO:0035325 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | DCAF1 TNIK MAPKAPK2 MINK1 MAP3K4 TAOK3 MAP4K5 MAP4K1 NRK TAOK1 MAP4K4 DCLK1 | 3.83e-05 | 446 | 131 | 12 | GO:0004674 |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 5.77e-05 | 149 | 131 | 7 | GO:1990782 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 7.04e-05 | 34 | 131 | 4 | GO:0015125 | |
| GeneOntologyMolecularFunction | glycolipid binding | 2.98e-04 | 49 | 131 | 4 | GO:0051861 | |
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 4.66e-04 | 55 | 131 | 4 | GO:0001046 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 8.02e-04 | 28 | 131 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 8.79e-04 | 65 | 131 | 4 | GO:0004714 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.16e-03 | 70 | 131 | 4 | GO:1901618 | |
| GeneOntologyMolecularFunction | neutral L-amino acid:sodium symporter activity | 1.17e-03 | 8 | 131 | 2 | GO:0005295 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 1.36e-03 | 73 | 131 | 4 | GO:0170055 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor binding | 1.42e-03 | 34 | 131 | 3 | GO:0050750 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.97e-03 | 38 | 131 | 3 | GO:0034061 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 2.12e-03 | 39 | 131 | 3 | GO:0070325 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 2.38e-03 | 85 | 131 | 4 | GO:0019199 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 2.47e-03 | 207 | 131 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 2.53e-03 | 208 | 131 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 2.70e-03 | 145 | 131 | 5 | GO:0004713 | |
| GeneOntologyMolecularFunction | co-SMAD binding | 2.70e-03 | 12 | 131 | 2 | GO:0070410 | |
| GeneOntologyMolecularFunction | actinin binding | 2.81e-03 | 43 | 131 | 3 | GO:0042805 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 2.92e-03 | 90 | 131 | 4 | GO:0008028 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 3.24e-03 | 293 | 131 | 7 | GO:0008514 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 3.30e-03 | 152 | 131 | 5 | GO:0016779 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB3 TNIK LHX4 FN1 ACHE NTRK2 SIPA1L3 MINK1 APBB1 RET SKIL ARHGEF25 TENM2 PDLIM5 HNRNPK FRY TAOK3 PTPRD F11R SMARCA4 OLFM1 PAX6 FGR MAP4K4 DCLK1 ZMYM4 | 1.44e-08 | 1194 | 127 | 26 | GO:0000902 |
| GeneOntologyBiologicalProcess | positive regulation of MAPK cascade | TNIK PSG1 PSG3 PSG11 NTRK2 MINK1 NAIP RET EZH2 MAP3K4 TAOK3 MAP4K1 NRK TENM1 TAOK1 PSG8 MAP4K4 | 8.27e-08 | 571 | 127 | 17 | GO:0043410 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | EPHB3 TNIK LHX4 FN1 ACHE NTRK2 MINK1 APBB1 RET SKIL ARHGEF25 TENM2 PDLIM5 HNRNPK TAOK3 PTPRD OLFM1 PAX6 MAP4K4 DCLK1 | 9.85e-08 | 802 | 127 | 20 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | EPHB3 TNIK LHX4 FN1 ACHE NTRK2 MINK1 APBB1 RET SKIL ARHGEF25 TENM2 PDLIM5 HNRNPK TAOK3 PTPRD OLFM1 PAX6 MAP4K4 DCLK1 | 1.38e-07 | 819 | 127 | 20 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | EPHB3 TNIK LHX4 FN1 ACHE NTRK2 MINK1 APBB1 RET SKIL ARHGEF25 TENM2 PDLIM5 HNRNPK TAOK3 PTPRD OLFM1 PAX6 MAP4K4 DCLK1 | 1.58e-07 | 826 | 127 | 20 | GO:0048858 |
| GeneOntologyBiologicalProcess | MAPK cascade | TNIK FN1 PSG1 PSG3 MAPKAPK2 PSG11 NTRK2 MINK1 NAIP RET EZH2 MAP3K4 TAOK3 MAP4K5 MAP4K1 NRK TENM1 TAOK1 RHBDD3 PSG8 MAP4K4 | 2.39e-07 | 930 | 127 | 21 | GO:0000165 |
| GeneOntologyBiologicalProcess | neuron development | EPHB3 TNIK LHX4 FN1 ACHE NTRK2 MINK1 APBB1 RET EZH2 SKIL ARHGEF25 TENM2 PDLIM5 HNRNPK FRY TAOK3 PTPRD AP2A1 TENM1 OLFM1 TAOK1 PAX6 GPC2 MAP4K4 DCLK1 | 7.79e-07 | 1463 | 127 | 26 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | EPHB3 EPHB4 TNIK FN1 PSG1 PSG3 ACHE PSG11 NTRK2 ADGRB2 GATA4 RET SKIL PDLIM5 HNRNPK PTPRD F11R AGTR2 PSG8 FGR NOS3 ZMYM4 | 7.99e-07 | 1090 | 127 | 22 | GO:0022603 |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB3 TNIK LHX4 FN1 ACHE NTRK2 MINK1 APBB1 RET EZH2 SKIL ARHGEF25 TENM2 PDLIM5 HNRNPK FRY TAOK3 PTPRD AP2A1 OLFM1 PAX6 GPC2 MAP4K4 DCLK1 | 9.37e-07 | 1285 | 127 | 24 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | EPHB3 TNIK FN1 ACHE NTRK2 APBB1 RET EZH2 SKIL PDLIM5 HNRNPK PTPRD AP2A1 PAX6 GPC2 MAP4K4 | 1.15e-06 | 612 | 127 | 16 | GO:0010975 |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 1.22e-06 | 31 | 127 | 5 | GO:0010544 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 1.31e-06 | 14 | 127 | 4 | GO:0070348 | |
| GeneOntologyBiologicalProcess | positive regulation of MAP kinase activity | 1.35e-06 | 129 | 127 | 8 | GO:0043406 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | EPHB3 EPHB4 TNIK MAPKAPK2 NTRK2 MINK1 TAOK3 MAP4K1 TAOK1 FGR | 1.51e-06 | 228 | 127 | 10 | GO:0046777 |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | TNIK IL12RB1 MAN2A1 FN1 PSG1 PSG3 TNFSF9 METRNL ACHE PSG11 NTRK2 RET EZH2 SKIL PTPRD F11R TP63 SMARCA4 OLFM1 DLX2 PSG8 PAX6 | 1.70e-06 | 1141 | 127 | 22 | GO:0045597 |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 1.78e-06 | 15 | 127 | 4 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 1.78e-06 | 15 | 127 | 4 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 1.78e-06 | 15 | 127 | 4 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.78e-06 | 15 | 127 | 4 | GO:0002859 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | TNIK FN1 ACHE NTRK2 APBB1 RET EZH2 SKIL TENM2 HNRNPK PTPRD AP2A1 TENM1 GPC2 | 2.22e-06 | 494 | 127 | 14 | GO:0031346 |
| GeneOntologyBiologicalProcess | insulin metabolic process | 2.29e-06 | 35 | 127 | 5 | GO:1901142 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 2.36e-06 | 16 | 127 | 4 | GO:0038016 | |
| GeneOntologyBiologicalProcess | regulation of MAPK cascade | TNIK FN1 PSG1 PSG3 PSG11 NTRK2 MINK1 NAIP RET EZH2 MAP3K4 TAOK3 MAP4K1 NRK TENM1 TAOK1 PSG8 MAP4K4 | 2.61e-06 | 815 | 127 | 18 | GO:0043408 |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | EPHB4 MAGI1 IL12RB1 FN1 PSG1 PSG3 TNFSF9 PSG11 GCNT1 RET CCDC88B F11R SMARCA4 PSG8 MAP4K4 | 2.85e-06 | 579 | 127 | 15 | GO:0045785 |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 3.07e-06 | 17 | 127 | 4 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 3.07e-06 | 17 | 127 | 4 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 3.07e-06 | 17 | 127 | 4 | GO:0038158 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 3.25e-06 | 66 | 127 | 6 | GO:0010543 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | EPHB3 TNIK LHX4 FN1 ACHE NTRK2 MINK1 APBB1 RET SKIL ARHGEF25 TENM2 PDLIM5 PTPRD OLFM1 PAX6 DCLK1 | 3.47e-06 | 748 | 127 | 17 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 3.92e-06 | 18 | 127 | 4 | GO:1903385 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | EPHB3 TNIK FN1 ACHE NTRK2 APBB1 RET EZH2 SKIL TENM2 PDLIM5 HNRNPK PTPRD AP2A1 TENM1 PAX6 GPC2 MAP4K4 | 4.38e-06 | 846 | 127 | 18 | GO:0120035 |
| GeneOntologyBiologicalProcess | positive regulation of JNK cascade | 4.45e-06 | 107 | 127 | 7 | GO:0046330 | |
| GeneOntologyBiologicalProcess | liver development | 4.54e-06 | 202 | 127 | 9 | GO:0001889 | |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 5.12e-06 | 205 | 127 | 9 | GO:0061008 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | EPHB4 MAGI1 IL12RB1 PSG1 PSG3 TNFSF9 PSG11 GCNT1 CCDC88B F11R SMARCA4 PSG8 | 5.23e-06 | 389 | 127 | 12 | GO:0022409 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | EPHB3 TNIK FN1 ACHE NTRK2 APBB1 RET EZH2 SKIL TENM2 PDLIM5 HNRNPK PTPRD AP2A1 TENM1 PAX6 GPC2 MAP4K4 | 5.76e-06 | 863 | 127 | 18 | GO:0031344 |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 5.79e-06 | 42 | 127 | 5 | GO:0090330 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 6.15e-06 | 20 | 127 | 4 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 7.56e-06 | 21 | 127 | 4 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 7.56e-06 | 21 | 127 | 4 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 7.56e-06 | 21 | 127 | 4 | GO:0002838 | |
| GeneOntologyBiologicalProcess | vasculogenesis | 8.50e-06 | 118 | 127 | 7 | GO:0001570 | |
| GeneOntologyBiologicalProcess | eye development | MAN2A1 ACHE NTRK2 SIPA1L3 RET SKIL CRX CRYBA2 SMARCA4 GSDMA DLX2 MYOM2 PAX6 | 8.52e-06 | 480 | 127 | 13 | GO:0001654 |
| GeneOntologyBiologicalProcess | visual system development | MAN2A1 ACHE NTRK2 SIPA1L3 RET SKIL CRX CRYBA2 SMARCA4 GSDMA DLX2 MYOM2 PAX6 | 9.10e-06 | 483 | 127 | 13 | GO:0150063 |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 9.20e-06 | 22 | 127 | 4 | GO:0030853 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | EPHB4 CDX4 MAN2A1 LHX4 PSG1 PSG3 PSG11 NTRK2 GATA4 ACTG2 GCNT1 CRX TP63 AGTR2 SMARCA4 OLFM1 DLX2 PSG8 PAX6 FGR NOS3 ALPL | 9.39e-06 | 1269 | 127 | 22 | GO:0009887 |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 1.02e-05 | 47 | 127 | 5 | GO:0034104 | |
| GeneOntologyBiologicalProcess | sensory system development | MAN2A1 ACHE NTRK2 SIPA1L3 RET SKIL CRX CRYBA2 SMARCA4 GSDMA DLX2 MYOM2 PAX6 | 1.08e-05 | 491 | 127 | 13 | GO:0048880 |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 1.11e-05 | 23 | 127 | 4 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.11e-05 | 23 | 127 | 4 | GO:0002858 | |
| GeneOntologyBiologicalProcess | regulation of cell development | TNIK IL12RB1 LILRB3 MAN2A1 FN1 PSG1 PSG3 TNFSF9 ACHE PSG11 NTRK2 RET EZH2 SKIL PTPRD F11R SMARCA4 DLX2 PSG8 PAX6 | 1.19e-05 | 1095 | 127 | 20 | GO:0060284 |
| GeneOntologyBiologicalProcess | camera-type eye development | MAN2A1 ACHE NTRK2 RET SKIL CRX CRYBA2 SMARCA4 GSDMA DLX2 MYOM2 PAX6 | 1.30e-05 | 426 | 127 | 12 | GO:0043010 |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 1.32e-05 | 24 | 127 | 4 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 1.32e-05 | 24 | 127 | 4 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 1.32e-05 | 24 | 127 | 4 | GO:0002420 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | EPHB3 EPHB4 MAGI1 IL12RB1 PSG1 PSG3 TNFSF9 PSG11 MINK1 GCNT1 CCDC88B F11R SMARCA4 PSG8 | 1.39e-05 | 580 | 127 | 14 | GO:0022407 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | EPHB3 EPHB4 MAGI1 IL12RB1 FN1 PSG1 PSG3 TNFSF9 PSG11 MINK1 GCNT1 RET BCAR1 CCDC88B F11R SMARCA4 PSG8 MAP4K4 | 1.52e-05 | 927 | 127 | 18 | GO:0030155 |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 1.57e-05 | 25 | 127 | 4 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 1.57e-05 | 25 | 127 | 4 | GO:0002423 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 1.63e-05 | 87 | 127 | 6 | GO:0001974 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 1.85e-05 | 53 | 127 | 5 | GO:0034110 | |
| GeneOntologyBiologicalProcess | response to hormone | PSG1 PSG3 ACHE PSG11 NTRK2 NAIP GATA4 GCNT1 BCAR1 EZH2 HNRNPK TP63 AGTR2 SMARCA4 PSG8 PAX6 NOS3 NPAS4 ALPL | 2.07e-05 | 1042 | 127 | 19 | GO:0009725 |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 2.16e-05 | 27 | 127 | 4 | GO:0070344 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 2.38e-05 | 93 | 127 | 6 | GO:1901184 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 2.50e-05 | 28 | 127 | 4 | GO:0034111 | |
| GeneOntologyBiologicalProcess | positive regulation of protein serine/threonine kinase activity | 2.64e-05 | 193 | 127 | 8 | GO:0071902 | |
| GeneOntologyBiologicalProcess | regulation of MAP kinase activity | 2.73e-05 | 194 | 127 | 8 | GO:0043405 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 2.89e-05 | 29 | 127 | 4 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 3.14e-05 | 59 | 127 | 5 | GO:0045671 | |
| GeneOntologyBiologicalProcess | JNK cascade | 3.16e-05 | 198 | 127 | 8 | GO:0007254 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | EPHB3 EPHB4 MAGI1 IL12RB1 PSG1 PSG3 TNFSF9 PSG11 MINK1 GCNT1 RET CCDC88B TENM2 PDLIM5 PTPRD F11R TENM1 SMARCA4 PSG8 | 3.26e-05 | 1077 | 127 | 19 | GO:0098609 |
| GeneOntologyBiologicalProcess | gland development | EPHB3 MAN2A1 PSG1 PSG3 PSG11 FPGS EZH2 TP63 SMARCA4 GSDMA RHBDD3 PSG8 PAX6 | 4.12e-05 | 558 | 127 | 13 | GO:0048732 |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | PSG1 PSG3 PSG11 NTRK2 NAIP GATA4 BCAR1 EZH2 HNRNPK TP63 AGTR2 SMARCA4 PSG8 PAX6 NPAS4 | 4.18e-05 | 727 | 127 | 15 | GO:0032870 |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | EPHB4 PSG1 PSG3 PSG11 NTRK2 RET EZH2 MAP3K4 TAOK3 TENM1 PSG8 | 4.23e-05 | 405 | 127 | 11 | GO:0033674 |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 4.31e-05 | 32 | 127 | 4 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 4.31e-05 | 32 | 127 | 4 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 4.31e-05 | 32 | 127 | 4 | GO:0060312 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular signal transduction | TNIK FN1 PSG1 PSG3 PSG11 NTRK2 MINK1 NAIP RET EZH2 SKIL MAP3K4 TAOK3 F11R MAP4K1 NRK TENM1 TAOK1 PSG8 FGR MAP4K4 | 4.32e-05 | 1299 | 127 | 21 | GO:1902533 |
| GeneOntologyBiologicalProcess | dendrite development | 4.36e-05 | 335 | 127 | 10 | GO:0016358 | |
| GeneOntologyBiologicalProcess | axonogenesis | EPHB3 LHX4 FN1 ACHE NTRK2 APBB1 RET SKIL ARHGEF25 TENM2 OLFM1 PAX6 DCLK1 | 4.77e-05 | 566 | 127 | 13 | GO:0007409 |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 4.88e-05 | 33 | 127 | 4 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 4.88e-05 | 33 | 127 | 4 | GO:2000252 | |
| GeneOntologyBiologicalProcess | response to insulin | 5.18e-05 | 342 | 127 | 10 | GO:0032868 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 5.51e-05 | 34 | 127 | 4 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 5.51e-05 | 34 | 127 | 4 | GO:0046851 | |
| GeneOntologyBiologicalProcess | ameboidal-type cell migration | EPHB4 FN1 PSG1 PSG3 PSG11 RET BCAR1 AGTR2 PSG8 PAX6 MAP4K4 NOS3 YTHDF3 | 5.80e-05 | 577 | 127 | 13 | GO:0001667 |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 5.82e-05 | 67 | 127 | 5 | GO:0045601 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell differentiation | 6.05e-05 | 217 | 127 | 8 | GO:0030856 | |
| GeneOntologyBiologicalProcess | ERBB signaling pathway | 6.08e-05 | 160 | 127 | 7 | GO:0038127 | |
| GeneOntologyBiologicalProcess | regulation of JNK cascade | 6.32e-05 | 161 | 127 | 7 | GO:0046328 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 6.70e-05 | 69 | 127 | 5 | GO:0030195 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | IL12RB1 FN1 TNFSF9 MAPKAPK2 NTRK2 POLR2A NAIP GATA4 ACTG2 RET CCDC88B HNRNPK AFAP1L2 AGTR2 SMARCA4 OLFM1 GSDMA PAX6 FGR FUBP3 NOS3 YTHDF3 | 6.87e-05 | 1446 | 127 | 22 | GO:0010628 |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 7.18e-05 | 70 | 127 | 5 | GO:1900047 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 7.50e-05 | 114 | 127 | 6 | GO:0045824 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 8.22e-05 | 72 | 127 | 5 | GO:0050819 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 8.60e-05 | 38 | 127 | 4 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 9.54e-05 | 39 | 127 | 4 | GO:0045717 | |
| GeneOntologyBiologicalProcess | cell junction organization | EPHB3 FN1 PSG1 PSG3 ACHE PSG11 NTRK2 ADGRB2 APBB1 PDLIM5 HNRNPK PTPRD F11R PSG8 MAP4K4 DCLK1 NPAS4 | 1.00e-04 | 974 | 127 | 17 | GO:0034330 |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.06e-04 | 40 | 127 | 4 | GO:0045953 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | TNIK IL12RB1 MAN2A1 FN1 TNFSF9 ACHE NTRK2 RET SKIL PTPRD F11R SMARCA4 PAX6 | 1.08e-04 | 614 | 127 | 13 | GO:0010720 |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 2.53e-06 | 16 | 131 | 4 | GO:0070021 | |
| GeneOntologyCellularComponent | endolysosome membrane | 2.54e-04 | 20 | 131 | 3 | GO:0036020 | |
| MousePheno | increased abdominal fat pad weight | 2.12e-06 | 27 | 112 | 5 | MP:0009286 | |
| MousePheno | increased physiological sensitivity to xenobiotic | PSG1 PSG3 ACHE PSG11 NTRK2 NAIP ABCB6 SKIL AGTR2 PSG8 NOS3 NPAS4 | 3.05e-06 | 286 | 112 | 12 | MP:0008873 |
| MousePheno | abnormal skeletal muscle triglyceride level | 4.34e-06 | 31 | 112 | 5 | MP:0031413 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 8.58e-06 | 17 | 112 | 4 | MP:0031047 | |
| MousePheno | abnormal muscle triglyceride level | 9.33e-06 | 36 | 112 | 5 | MP:0031412 | |
| MousePheno | increased skeletal muscle triglyceride level | 2.10e-05 | 21 | 112 | 4 | MP:0031415 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 2.55e-05 | 44 | 112 | 5 | MP:0031023 | |
| MousePheno | decreased fatty acid oxidation | 3.67e-05 | 24 | 112 | 4 | MP:0014172 | |
| MousePheno | absent sebaceous gland | 6.36e-05 | 2 | 112 | 2 | MP:0000648 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 6.89e-05 | 28 | 112 | 4 | MP:0020950 | |
| MousePheno | abnormal induced morbidity/mortality | RHCG PSG1 PSG3 METRNL ACHE MAPKAPK2 PSG11 ABCB6 SKIL CCDC88B AGTR2 GSDMA RHBDD3 PSG8 NOS3 NPAS4 YTHDF3 | 7.58e-05 | 737 | 112 | 17 | MP:0001657 |
| MousePheno | decreased carbon dioxide production | 1.04e-04 | 31 | 112 | 4 | MP:0008964 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 1.16e-04 | 60 | 112 | 5 | MP:0009790 | |
| MousePheno | abnormal tumor incidence | TNIK PSG1 PSG3 MAPKAPK2 PSG11 POLE AIP RET SKIL B9D2 TP63 AGTR2 SMARCA4 PSG8 PAX6 | 1.61e-04 | 635 | 112 | 15 | MP:0002019 |
| MousePheno | decreased skeletal muscle cell glucose uptake | 1.69e-04 | 35 | 112 | 4 | MP:0031618 | |
| MousePheno | increased susceptibility to neuronal excitotoxicity | 1.89e-04 | 36 | 112 | 4 | MP:0008235 | |
| MousePheno | abnormal tumor susceptibility | TNIK PSG1 PSG3 MAPKAPK2 PSG11 POLE AIP RET SKIL B9D2 TP63 AGTR2 SMARCA4 PSG8 PAX6 | 2.08e-04 | 650 | 112 | 15 | MP:0002166 |
| MousePheno | abnormal physiological response to xenobiotic | TNIK PSG1 PSG3 ACHE MAPKAPK2 PSG11 NTRK2 NAIP ABCB6 SKIL AGTR2 RHBDD3 PSG8 NOS3 NPAS4 | 2.53e-04 | 662 | 112 | 15 | MP:0008872 |
| MousePheno | decreased muscle cell glucose uptake | 2.59e-04 | 39 | 112 | 4 | MP:0030022 | |
| MousePheno | abnormal vascular wound healing | 2.94e-04 | 73 | 112 | 5 | MP:0004883 | |
| MousePheno | decreased susceptibility to infection induced morbidity/mortality | 4.03e-04 | 120 | 112 | 6 | MP:0009786 | |
| MousePheno | abnormal susceptibility to infection induced morbidity/mortality | 4.04e-04 | 279 | 112 | 9 | MP:0009785 | |
| Domain | CNH | 2.18e-10 | 14 | 124 | 6 | SM00036 | |
| Domain | CNH | 3.61e-10 | 15 | 124 | 6 | PF00780 | |
| Domain | CNH | 3.61e-10 | 15 | 124 | 6 | PS50219 | |
| Domain | CNH_dom | 3.61e-10 | 15 | 124 | 6 | IPR001180 | |
| Domain | Protein_kinase_ATP_BS | EPHB3 EPHB4 TNIK MAPKAPK2 NTRK2 MINK1 RET MAP3K4 TAOK3 MAP4K5 MAP4K1 NRK TAOK1 FGR MAP4K4 DCLK1 | 4.47e-09 | 379 | 124 | 16 | IPR017441 |
| Domain | PROTEIN_KINASE_ATP | EPHB3 EPHB4 TNIK MAPKAPK2 NTRK2 MINK1 RET MAP3K4 TAOK3 MAP4K5 MAP4K1 NRK TAOK1 FGR MAP4K4 DCLK1 | 6.51e-08 | 459 | 124 | 16 | PS00107 |
| Domain | Prot_kinase_dom | EPHB3 EPHB4 TNIK MAPKAPK2 NTRK2 MINK1 RET MAP3K4 TAOK3 MAP4K5 MAP4K1 NRK TAOK1 FGR MAP4K4 DCLK1 | 1.54e-07 | 489 | 124 | 16 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | EPHB3 EPHB4 TNIK MAPKAPK2 NTRK2 MINK1 RET MAP3K4 TAOK3 MAP4K5 MAP4K1 NRK TAOK1 FGR MAP4K4 DCLK1 | 1.72e-07 | 493 | 124 | 16 | PS50011 |
| Domain | Kinase-like_dom | EPHB3 EPHB4 TNIK MAPKAPK2 NTRK2 MINK1 RET MAP3K4 TAOK3 MAP4K5 MAP4K1 NRK TAOK1 FGR MAP4K4 DCLK1 | 6.12e-07 | 542 | 124 | 16 | IPR011009 |
| Domain | ig | 5.01e-06 | 190 | 124 | 9 | PF00047 | |
| Domain | Immunoglobulin | 5.01e-06 | 190 | 124 | 9 | IPR013151 | |
| Domain | Ser/Thr_kinase_AS | TNIK MAPKAPK2 MINK1 MAP3K4 TAOK3 MAP4K5 MAP4K1 NRK TAOK1 MAP4K4 DCLK1 | 2.63e-05 | 357 | 124 | 11 | IPR008271 |
| Domain | IGc2 | 2.74e-05 | 235 | 124 | 9 | SM00408 | |
| Domain | Ig_sub2 | 2.74e-05 | 235 | 124 | 9 | IPR003598 | |
| Domain | S_TKc | TNIK MAPKAPK2 MINK1 MAP3K4 TAOK3 MAP4K5 MAP4K1 NRK TAOK1 MAP4K4 DCLK1 | 2.77e-05 | 359 | 124 | 11 | SM00220 |
| Domain | PROTEIN_KINASE_ST | TNIK MAPKAPK2 MINK1 MAP3K4 TAOK3 MAP4K5 MAP4K1 NRK TAOK1 MAP4K4 DCLK1 | 2.99e-05 | 362 | 124 | 11 | PS00108 |
| Domain | Phosphofurin_acidic_CS-1 | 4.37e-05 | 2 | 124 | 2 | IPR019381 | |
| Domain | Pacs-1 | 4.37e-05 | 2 | 124 | 2 | PF10254 | |
| Domain | - | 4.37e-05 | 2 | 124 | 2 | 2.60.40.1030 | |
| Domain | Clathrin_a-adaptin_app_Ig-like | 4.37e-05 | 2 | 124 | 2 | IPR013038 | |
| Domain | AP2_complex_asu | 4.37e-05 | 2 | 124 | 2 | IPR017104 | |
| Domain | Clathrin_a-adaptin_app_sub_C | 4.37e-05 | 2 | 124 | 2 | IPR003164 | |
| Domain | Alpha_adaptin_C | 4.37e-05 | 2 | 124 | 2 | PF02296 | |
| Domain | Pkinase | TNIK MAPKAPK2 MINK1 MAP3K4 TAOK3 MAP4K5 MAP4K1 NRK TAOK1 MAP4K4 DCLK1 | 4.75e-05 | 381 | 124 | 11 | PF00069 |
| Domain | Ig-like_fold | EPHB3 EPHB4 IL12RB1 LILRB3 FN1 PSG1 PSG3 PSG7 PSG11 NTRK2 PTPRD F11R IGHE PSG8 MYOM2 | 6.91e-05 | 706 | 124 | 15 | IPR013783 |
| Domain | Ig_2 | 1.25e-04 | 73 | 124 | 5 | PF13895 | |
| Domain | Tox-GHH_dom | 2.60e-04 | 4 | 124 | 2 | IPR028916 | |
| Domain | Tox-GHH | 2.60e-04 | 4 | 124 | 2 | PF15636 | |
| Domain | Clathrin_a/coatomer_app_sub_C | 2.60e-04 | 4 | 124 | 2 | IPR015873 | |
| Domain | MAPKKKK | 2.60e-04 | 4 | 124 | 2 | IPR021160 | |
| Domain | Ten_N | 2.60e-04 | 4 | 124 | 2 | IPR009471 | |
| Domain | Ten_N | 2.60e-04 | 4 | 124 | 2 | PF06484 | |
| Domain | TENEURIN_N | 2.60e-04 | 4 | 124 | 2 | PS51361 | |
| Domain | - | 2.60e-04 | 4 | 124 | 2 | 3.30.310.30 | |
| Domain | Tyr_kinase_cat_dom | 3.00e-04 | 88 | 124 | 5 | IPR020635 | |
| Domain | TyrKc | 3.00e-04 | 88 | 124 | 5 | SM00219 | |
| Domain | Quino_amine_DH_bsu | 4.01e-04 | 22 | 124 | 3 | IPR011044 | |
| Domain | YD | 4.32e-04 | 5 | 124 | 2 | IPR006530 | |
| Domain | IG_LIKE | LILRB3 PSG1 PSG3 PSG7 PSG11 NTRK2 PTPRD F11R IGHE PSG8 MYOM2 | 4.33e-04 | 491 | 124 | 11 | PS50835 |
| Domain | - | EPHB3 EPHB4 IL12RB1 FN1 PSG1 PSG3 PSG7 PSG11 NTRK2 PTPRD F11R PSG8 MYOM2 | 4.67e-04 | 663 | 124 | 13 | 2.60.40.10 |
| Domain | PROTEIN_KINASE_TYR | 4.71e-04 | 97 | 124 | 5 | PS00109 | |
| Domain | Tyr_kinase_AS | 4.71e-04 | 97 | 124 | 5 | IPR008266 | |
| Domain | IG | 5.06e-04 | 421 | 124 | 10 | SM00409 | |
| Domain | Ig_sub | 5.06e-04 | 421 | 124 | 10 | IPR003599 | |
| Domain | Ig-like_dom | LILRB3 PSG1 PSG3 PSG7 PSG11 NTRK2 PTPRD F11R IGHE PSG8 MYOM2 | 5.30e-04 | 503 | 124 | 11 | IPR007110 |
| Domain | fn3 | 7.46e-04 | 162 | 124 | 6 | PF00041 | |
| Domain | Coatomer/calthrin_app_sub_C | 1.19e-03 | 8 | 124 | 2 | IPR009028 | |
| Domain | V-set | 1.44e-03 | 184 | 124 | 6 | PF07686 | |
| Domain | FN3 | 1.48e-03 | 185 | 124 | 6 | SM00060 | |
| Domain | Alpha_adaptinC2 | 1.53e-03 | 9 | 124 | 2 | PF02883 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 1.53e-03 | 9 | 124 | 2 | IPR008152 | |
| Domain | Alpha_adaptinC2 | 1.53e-03 | 9 | 124 | 2 | SM00809 | |
| Domain | Pkinase_Tyr | 1.70e-03 | 129 | 124 | 5 | PF07714 | |
| Domain | FN3 | 2.14e-03 | 199 | 124 | 6 | PS50853 | |
| Domain | Ig_V-set | 2.14e-03 | 199 | 124 | 6 | IPR013106 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 2.28e-03 | 138 | 124 | 5 | IPR001245 | |
| Domain | Ephrin_rec_like | 2.31e-03 | 11 | 124 | 2 | PF07699 | |
| Domain | DUF1220 | 2.31e-03 | 11 | 124 | 2 | PF06758 | |
| Domain | NBPF_dom | 2.31e-03 | 11 | 124 | 2 | IPR010630 | |
| Domain | NBPF | 2.31e-03 | 11 | 124 | 2 | PS51316 | |
| Domain | FN3_dom | 2.73e-03 | 209 | 124 | 6 | IPR003961 | |
| Domain | Coatomer/clathrin_app_Ig-like | 2.76e-03 | 12 | 124 | 2 | IPR013041 | |
| Domain | NHL | 3.25e-03 | 13 | 124 | 2 | PS51125 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 3.78e-03 | 14 | 124 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 3.78e-03 | 14 | 124 | 2 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 3.78e-03 | 14 | 124 | 2 | IPR001426 | |
| Domain | ATPase_dyneun-rel_AAA | 3.78e-03 | 14 | 124 | 2 | IPR011704 | |
| Domain | EphA2_TM | 3.78e-03 | 14 | 124 | 2 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 3.78e-03 | 14 | 124 | 2 | IPR001090 | |
| Domain | Eph_TM | 3.78e-03 | 14 | 124 | 2 | IPR027936 | |
| Domain | EPH_lbd | 3.78e-03 | 14 | 124 | 2 | SM00615 | |
| Domain | Ephrin_lbd | 3.78e-03 | 14 | 124 | 2 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 3.78e-03 | 14 | 124 | 2 | IPR016257 | |
| Domain | EPH_LBD | 3.78e-03 | 14 | 124 | 2 | PS51550 | |
| Domain | AAA_5 | 3.78e-03 | 14 | 124 | 2 | PF07728 | |
| Domain | VWF_A | 4.29e-03 | 99 | 124 | 4 | IPR002035 | |
| Domain | Clathrin/coatomer_adapt-like_N | 4.34e-03 | 15 | 124 | 2 | IPR002553 | |
| Domain | Adaptin_N | 4.34e-03 | 15 | 124 | 2 | PF01602 | |
| Domain | FKBP_PPIASE | 4.94e-03 | 16 | 124 | 2 | PS50059 | |
| Domain | FKBP_C | 4.94e-03 | 16 | 124 | 2 | PF00254 | |
| Domain | Gal_mutarotase_SF_dom | 5.57e-03 | 17 | 124 | 2 | IPR011013 | |
| Domain | VWA | 6.13e-03 | 56 | 124 | 3 | PF00092 | |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | 3.92e-06 | 37 | 92 | 5 | MM14899 | |
| Pathway | WP_HIPPOYAP_SIGNALING | 1.14e-05 | 22 | 92 | 4 | M39821 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 1.36e-04 | 76 | 92 | 5 | MM1433 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 1.84e-04 | 81 | 92 | 5 | M13863 | |
| Pathway | PID_TNF_PATHWAY | 2.25e-04 | 46 | 92 | 4 | M128 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 2.26e-04 | 188 | 92 | 7 | MM15828 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 2.44e-04 | 47 | 92 | 4 | M39829 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 2.74e-04 | 194 | 92 | 7 | M16312 | |
| Pathway | REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS | 3.29e-04 | 21 | 92 | 3 | M12347 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 3.36e-04 | 51 | 92 | 4 | M27311 | |
| Pubmed | FN1 TTC28 SIPA1L3 APBB1 NCKAP5 AIP SKIL TUBGCP5 PDLIM5 HNRNPK FRY PTPRD AP2A1 SACS NMT2 SMARCA4 OLFM1 TAOK1 PAX6 MAP4K4 DCLK1 ZMYM4 ALPL | 5.96e-10 | 1285 | 132 | 23 | 35914814 | |
| Pubmed | A ciliopathy complex at the transition zone protects the cilia as a privileged membrane domain. | 6.66e-09 | 38 | 132 | 6 | 22179047 | |
| Pubmed | TNIK MAGI1 NTRK2 SIPA1L3 MINK1 ADGRB2 TENM2 HNRNPK FRY PTPRD AP2A1 AP2A2 TAX1BP1 SEC16A SMARCA4 MAP4K4 DCLK1 SEC23A | 2.77e-08 | 963 | 132 | 18 | 28671696 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | EPHB4 TMEM94 MAPKAPK2 MINK1 EFCAB14 AIP RET BCAR1 MAP3K4 TAOK3 AP2A1 AP2A2 MAP4K5 MAP4K1 NRK NMT2 MAP4K4 | 7.02e-08 | 910 | 132 | 17 | 36736316 |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 1.38e-07 | 13 | 132 | 4 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 1.38e-07 | 13 | 132 | 4 | 19273835 | |
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 20044046 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 32150576 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 6265583 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 1.38e-07 | 13 | 132 | 4 | 12832451 | |
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 25406283 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 8380065 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 1279194 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 25724769 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 1.38e-07 | 13 | 132 | 4 | 22092845 | |
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 1.38e-07 | 13 | 132 | 4 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 1.38e-07 | 13 | 132 | 4 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 1.38e-07 | 13 | 132 | 4 | 23800882 | |
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 19285068 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 1.38e-07 | 13 | 132 | 4 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 1.38e-07 | 13 | 132 | 4 | 39168268 | |
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 8402684 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 1.38e-07 | 13 | 132 | 4 | 21949477 | |
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 26219866 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 2133556 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 19621080 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 1.38e-07 | 13 | 132 | 4 | 19358828 | |
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 16680193 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 1.38e-07 | 13 | 132 | 4 | 34058224 | |
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 10964771 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 1.38e-07 | 13 | 132 | 4 | 23935487 | |
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 1.38e-07 | 13 | 132 | 4 | 25972571 | |
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 1.38e-07 | 13 | 132 | 4 | 15220458 | |
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 18843289 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 15207636 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 21081647 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 11133662 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 11483763 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 18003729 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 20739537 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 1.38e-07 | 13 | 132 | 4 | 27695943 | |
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 20404914 | ||
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 1.38e-07 | 13 | 132 | 4 | 16638824 | |
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 34440862 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 1.38e-07 | 13 | 132 | 4 | 21670291 | |
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 22162753 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 2702644 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 11801635 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 21760897 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 1719235 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 16619040 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 1.38e-07 | 13 | 132 | 4 | 8209741 | |
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 32521208 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 19406938 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 1.38e-07 | 13 | 132 | 4 | 29967450 | |
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 1653760 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 32169849 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 1.38e-07 | 13 | 132 | 4 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 1.38e-07 | 13 | 132 | 4 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 1.38e-07 | 13 | 132 | 4 | 15316023 | |
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 15331748 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 1.38e-07 | 13 | 132 | 4 | 22406619 | |
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 7628460 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 19008452 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 2164599 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 29396368 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 1.38e-07 | 13 | 132 | 4 | 33352461 | |
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 38381498 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 1633107 | ||
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 1.38e-07 | 13 | 132 | 4 | 32027621 | |
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 1.38e-07 | 13 | 132 | 4 | 27777319 | |
| Pubmed | 1.38e-07 | 13 | 132 | 4 | 18848945 | ||
| Pubmed | 1.93e-07 | 14 | 132 | 4 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 1.93e-07 | 14 | 132 | 4 | 34666041 | |
| Pubmed | 1.93e-07 | 14 | 132 | 4 | 34619794 | ||
| Pubmed | 1.93e-07 | 14 | 132 | 4 | 8896983 | ||
| Pubmed | 1.93e-07 | 14 | 132 | 4 | 22962327 | ||
| Pubmed | 1.93e-07 | 14 | 132 | 4 | 17623671 | ||
| Pubmed | 1.93e-07 | 14 | 132 | 4 | 26846848 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 1.93e-07 | 14 | 132 | 4 | 18794798 | |
| Pubmed | 1.93e-07 | 14 | 132 | 4 | 23469261 | ||
| Pubmed | 1.93e-07 | 14 | 132 | 4 | 18454175 | ||
| Pubmed | 1.93e-07 | 14 | 132 | 4 | 29907459 | ||
| Pubmed | 1.93e-07 | 14 | 132 | 4 | 36719377 | ||
| Pubmed | 1.93e-07 | 14 | 132 | 4 | 28567513 | ||
| Pubmed | 1.93e-07 | 14 | 132 | 4 | 8207827 | ||
| Pubmed | 1.93e-07 | 14 | 132 | 4 | 19700760 | ||
| Pubmed | 1.93e-07 | 14 | 132 | 4 | 9212243 | ||
| Pubmed | 1.93e-07 | 14 | 132 | 4 | 1648219 | ||
| Pubmed | 1.93e-07 | 14 | 132 | 4 | 14517298 | ||
| Interaction | PSG4 interactions | 1.10e-07 | 8 | 129 | 4 | int:PSG4 | |
| Interaction | COLQ interactions | 2.04e-06 | 33 | 129 | 5 | int:COLQ | |
| Interaction | STARD13 interactions | 4.84e-06 | 68 | 129 | 6 | int:STARD13 | |
| Interaction | ZNF462 interactions | 4.84e-06 | 68 | 129 | 6 | int:ZNF462 | |
| Interaction | NCK2 interactions | ARHGAP42 TNIK TTC28 NTRK2 MINK1 RET BCAR1 HNRNPK MAP4K1 MAP4K4 | 7.36e-06 | 262 | 129 | 10 | int:NCK2 |
| Interaction | MYO6 interactions | DCAF1 MAGI1 NTRK2 POLR2A SIPA1L3 PARP4 DPP9 AP2A1 AP2A2 TAX1BP1 SEC16A MAP4K4 | 9.77e-06 | 398 | 129 | 12 | int:MYO6 |
| Interaction | EBAG9 interactions | POLR2A APBB1 SLC6A15 COG3 AP2A1 AP2A2 MAP4K5 SEC16A MAP4K4 SEC23A | 2.59e-05 | 303 | 129 | 10 | int:EBAG9 |
| Interaction | GAA interactions | 2.62e-05 | 135 | 129 | 7 | int:GAA | |
| Interaction | NCK1 interactions | 2.80e-05 | 244 | 129 | 9 | int:NCK1 | |
| Interaction | TNRC6C interactions | 3.02e-05 | 138 | 129 | 7 | int:TNRC6C | |
| Interaction | EPHA5 interactions | 3.97e-05 | 144 | 129 | 7 | int:EPHA5 | |
| Interaction | NLGN3 interactions | 4.21e-05 | 99 | 129 | 6 | int:NLGN3 | |
| Interaction | CSNK2B interactions | FN1 MAPKAPK2 POLR2A MINK1 GATA4 EFCAB14 EZH2 PACS1 MAP4K1 TP63 NMT2 TENM1 MAP4K4 ZMYM4 | 4.83e-05 | 625 | 129 | 14 | int:CSNK2B |
| Interaction | CHD7 interactions | 5.15e-05 | 150 | 129 | 7 | int:CHD7 | |
| Interaction | RPL13AP3 interactions | 5.68e-05 | 33 | 129 | 4 | int:RPL13AP3 | |
| Interaction | AVPR1B interactions | 5.68e-05 | 33 | 129 | 4 | int:AVPR1B | |
| Interaction | AFDN interactions | EPHB3 MAGI1 FN1 NTRK2 SIPA1L3 MINK1 SLC6A15 F11R MAP4K4 DCLK1 | 5.74e-05 | 333 | 129 | 10 | int:AFDN |
| Interaction | GRB2 interactions | DCAF1 FN1 NTRK2 POLR2A MINK1 RET BCAR1 PTPN18 PDLIM5 HNRNPK AP2A1 AP2A2 MAP4K5 MAP4K1 TP63 MAP4K4 | 5.78e-05 | 806 | 129 | 16 | int:GRB2 |
| Interaction | ALK interactions | 6.33e-05 | 271 | 129 | 9 | int:ALK | |
| Interaction | NEFL interactions | 8.06e-05 | 161 | 129 | 7 | int:NEFL | |
| Interaction | ELOF1 interactions | 9.23e-05 | 71 | 129 | 5 | int:ELOF1 | |
| Interaction | ARF6 interactions | EPHB4 TNIK FN1 MINK1 APBB1 SLC6A15 COG3 EZH2 F11R AP2A1 MAP4K5 NMT2 MAP4K4 | 9.70e-05 | 584 | 129 | 13 | int:ARF6 |
| Interaction | EPHA8 interactions | 1.09e-04 | 169 | 129 | 7 | int:EPHA8 | |
| Interaction | DSCAM interactions | 1.17e-04 | 171 | 129 | 7 | int:DSCAM | |
| Interaction | PSG8 interactions | 1.35e-04 | 41 | 129 | 4 | int:PSG8 | |
| Interaction | RAC1 interactions | ARHGAP42 EPHB4 TNIK MAGI1 FN1 SIPA1L3 MINK1 SLC6A15 BCAR1 ARHGEF25 HNRNPK MAP3K4 PACS1 TAOK3 AP2A2 MAP4K5 MAP4K4 ALPL | 1.48e-04 | 1063 | 129 | 18 | int:RAC1 |
| Interaction | SEC24B interactions | 1.59e-04 | 240 | 129 | 8 | int:SEC24B | |
| Interaction | FOXE1 interactions | 1.73e-04 | 81 | 129 | 5 | int:FOXE1 | |
| Interaction | AGO1 interactions | 1.79e-04 | 183 | 129 | 7 | int:AGO1 | |
| Interaction | SMARCD2 interactions | 1.79e-04 | 183 | 129 | 7 | int:SMARCD2 | |
| Interaction | PBX1 interactions | 2.16e-04 | 85 | 129 | 5 | int:PBX1 | |
| Interaction | SMAP2 interactions | 2.18e-04 | 189 | 129 | 7 | int:SMAP2 | |
| Interaction | CPB2 interactions | 2.30e-04 | 19 | 129 | 3 | int:CPB2 | |
| Cytoband | 19q13.2 | 8.56e-06 | 164 | 132 | 6 | 19q13.2 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 1.16e-09 | 11 | 89 | 5 | 1315 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinase kinases | 1.14e-06 | 5 | 89 | 3 | 655 | |
| GeneFamily | Neuroblastoma breakpoint family | 4.52e-06 | 23 | 89 | 4 | 662 | |
| GeneFamily | Fibronectin type III domain containing | 1.39e-04 | 160 | 89 | 6 | 555 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 2.17e-04 | 24 | 89 | 3 | 654 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.26e-03 | 163 | 89 | 5 | 590 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 2.10e-03 | 14 | 89 | 2 | 1095 | |
| GeneFamily | Dyneins, axonemal | 3.11e-03 | 17 | 89 | 2 | 536 | |
| GeneFamily | FKBP prolyl isomerases | 3.48e-03 | 18 | 89 | 2 | 910 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 1.91e-08 | 35 | 130 | 6 | MM757 | |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | WIPI1 FN1 PSG3 ACHE PSG11 NTRK2 FKBP9 ABCB6 TEP1 PTPRD AGTR2 SEC16A | 5.29e-06 | 482 | 130 | 12 | M12144 |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 1.87e-05 | 32 | 130 | 4 | MM2 | |
| Coexpression | GARY_CD5_TARGETS_UP | TNFSF9 METRNL MINK1 AIP PACS1 AP2A1 MAP4K1 TAOK1 FGR NOS3 KDM4B | 2.49e-05 | 473 | 130 | 11 | M17693 |
| Coexpression | LEE_AGING_CEREBELLUM_DN | 3.18e-05 | 73 | 130 | 5 | M1544 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 3.63e-05 | 75 | 130 | 5 | MM605 | |
| Coexpression | LEE_AGING_CEREBELLUM_DN | 3.63e-05 | 75 | 130 | 5 | MM662 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | FN1 NBEAL1 ACHE SKIL PDLIM5 PACS1 TAOK3 TP63 TAX1BP1 MAP4K4 DCLK1 | 4.43e-05 | 504 | 130 | 11 | M2157 |
| Coexpression | GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_UP | 4.85e-05 | 191 | 130 | 7 | M3298 | |
| Coexpression | GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_DN | 6.49e-05 | 200 | 130 | 7 | M7469 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_UP | 7.22e-05 | 140 | 130 | 6 | M617 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_UP | 9.11e-05 | 146 | 130 | 6 | MM964 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 9.49e-05 | 48 | 130 | 4 | MM531 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 1.02e-04 | 93 | 130 | 5 | M40279 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 1.14e-04 | 219 | 130 | 7 | MM3826 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_MATURE_CELL | 1.24e-04 | 298 | 130 | 8 | M11205 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 9.90e-08 | 192 | 130 | 8 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 7.22e-07 | 171 | 130 | 7 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|(0)_Normal/No_Treatment / Stress and Cell class | 7.81e-07 | 173 | 130 | 7 | c2a0f674681836b5a868c13f67caa7d555ef6519 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.45e-07 | 178 | 130 | 7 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 184 | 130 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 184 | 130 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 184 | 130 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.31e-06 | 187 | 130 | 7 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-06 | 189 | 130 | 7 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-06 | 189 | 130 | 7 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-06 | 189 | 130 | 7 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.62e-06 | 193 | 130 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.74e-06 | 195 | 130 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-06 | 165 | 130 | 6 | 11227bff52eed30b80937fdb1968d0b8e6d30365 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-06 | 165 | 130 | 6 | 036f9749048e5e50769cc3210339bf4da469215d | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.01e-05 | 168 | 130 | 6 | ba9ddd403ee6d6af2fe56dffbd419764bfb703e4 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-classical_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.01e-05 | 168 | 130 | 6 | af4c35c0d3f030cef8397c35fa498a71112bb16b | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-05 | 170 | 130 | 6 | 138235227fc4c3d660c3a06e8e5167bf64f076b3 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.15e-05 | 172 | 130 | 6 | a53c906539557594ef10368bc29aec4af063fd37 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 173 | 130 | 6 | 807183fc23478da9451906dacd88de4e73112e0d | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 173 | 130 | 6 | 2e683ec555dc0036875e0f5674dcc5e93ead205d | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-05 | 173 | 130 | 6 | 9acad7ec70f713fe3db6cef7bbe3b183bf16ae67 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l14|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.23e-05 | 174 | 130 | 6 | 02ab165b064acb91f2d3f59cc5be195899d61a83 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-05 | 176 | 130 | 6 | 8f9d2a763b79cafe26dcbf3dba980d473a0b9873 | |
| ToppCell | AT1-AT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.31e-05 | 176 | 130 | 6 | f86832cfeff5b3cfffe4455c1b96a1420d48ba1e | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-classical_monocyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-05 | 176 | 130 | 6 | 3b5d12d5c22e32fbe80c3716ff14a7ae5769c165 | |
| ToppCell | facs-Lung-Endomucin-24m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 182 | 130 | 6 | be9c312a44868d4ee266a64d066feb8c5bce5687 | |
| ToppCell | facs-Lung-Endomucin-24m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 182 | 130 | 6 | 74dbb706bcaa0f8c922bf3b0424bce5bb27167fa | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 182 | 130 | 6 | ef65b095f4240d61cfd4a59aec19d72d324dba1d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 182 | 130 | 6 | 97a805783a1f2b055c21307db250e3688674eff3 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.64e-05 | 183 | 130 | 6 | f517215ff45dec914af52dfdbc4579c19654c3aa | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.64e-05 | 183 | 130 | 6 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 1.69e-05 | 184 | 130 | 6 | 684d05340a3dfb8aa08b881516a37f9627a10448 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.74e-05 | 185 | 130 | 6 | c85bba1210f1d389add3e40be9b96abac40cf8c1 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.74e-05 | 185 | 130 | 6 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.80e-05 | 186 | 130 | 6 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 186 | 130 | 6 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-05 | 186 | 130 | 6 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.97e-05 | 189 | 130 | 6 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 189 | 130 | 6 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.02e-05 | 190 | 130 | 6 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-RG-RG-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.02e-05 | 190 | 130 | 6 | 7a560d046aeff979cdf543c519e4e51280f5e232 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.02e-05 | 190 | 130 | 6 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 2.02e-05 | 190 | 130 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | facs-SCAT-Fat-3m-Endothelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 191 | 130 | 6 | a0018f88f7132477cc467ee15db029a585290595 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 191 | 130 | 6 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.09e-05 | 191 | 130 | 6 | 053b3664f509baa107feaf90730f80ebf9ac8f14 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 2.09e-05 | 191 | 130 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | facs-SCAT-Fat-3m-Endothelial-endothelial_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 191 | 130 | 6 | 6b9bbf4a63d4e9a8075bb06c2aa644fcf4ee88b8 | |
| ToppCell | facs-SCAT-Fat-3m-Endothelial|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-05 | 191 | 130 | 6 | 90f0c193dce267a4f1a9b2501f636dafd0a34cf7 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 193 | 130 | 6 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 193 | 130 | 6 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 2.28e-05 | 194 | 130 | 6 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | 18-Airway-Epithelial-Epithelial|Airway / Age, Tissue, Lineage and Cell class | 2.28e-05 | 194 | 130 | 6 | d3c90e1f1228f8ba0ba56105c6cf4f302c388f28 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.34e-05 | 195 | 130 | 6 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 195 | 130 | 6 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | facs-GAT-Fat-3m-Endothelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 196 | 130 | 6 | b6cc1f466d45479764080d34b1daeb8243a5a9f3 | |
| ToppCell | facs-GAT-Fat-3m-Endothelial-endothelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 196 | 130 | 6 | ede6104cdfa4ee5287efcca9bbc36677cbf7a8d8 | |
| ToppCell | facs-GAT-Fat-3m-Endothelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 196 | 130 | 6 | 039044ab28c53391c34d8226fb8cf78549e63ef4 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.48e-05 | 197 | 130 | 6 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.48e-05 | 197 | 130 | 6 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.48e-05 | 197 | 130 | 6 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 2.70e-05 | 200 | 130 | 6 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Interneuron|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.70e-05 | 200 | 130 | 6 | 274871d632bbbe03720726a59ab3ec6d5fa0da11 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Meis2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.70e-05 | 68 | 130 | 4 | 3c5d0d35e4d1c5506a4a490e2f93e8024294207f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Meis2-Meis2_Adamts19|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.70e-05 | 68 | 130 | 4 | 3a61ea2b234829632fabede72761aa6664550e56 | |
| ToppCell | facs-Aorta-Heart-24m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 146 | 130 | 5 | d8d24851e8d8d90795a6f9378418f209200d55b1 | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 7.17e-05 | 147 | 130 | 5 | 87c24843cb0e87ad42e725d08423131a5d2d25a3 | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-05 | 151 | 130 | 5 | a7b1a60d68f0ed17022fe4c97af64f9f08d39fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-05 | 152 | 130 | 5 | d279592c501fca9cb474ad916fea32282e6969cb | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-05 | 152 | 130 | 5 | 3b59143b2b4ee24eb6378f87ff568124193256e9 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-leukocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.66e-05 | 153 | 130 | 5 | 8cc2667213bfac37545bb63181e88ef1f1834413 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-leukocyte-proliferating_myeloid_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.66e-05 | 153 | 130 | 5 | 596bb7cfd1c713708ce73df30d890a0233eae7f7 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.93e-05 | 154 | 130 | 5 | 27f76e4b3c055aa382708f1610c685f02d6d6114 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.93e-05 | 154 | 130 | 5 | 8746663a822d93a8510081c81a8c971b51653067 | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.49e-05 | 156 | 130 | 5 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.07e-04 | 160 | 130 | 5 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | (1)_Control_(PBS)-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 1.07e-04 | 160 | 130 | 5 | ab769516f9f7798d1390ef215caf22a2d3d53e63 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 160 | 130 | 5 | 822adcf5f9208f305cafffd8ed97f3a061e82b03 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 162 | 130 | 5 | 8a488ecd25ef41468c3c7766eb936dbc2f7665a9 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 162 | 130 | 5 | 76e289ad9fd3694f77fd0d19e74c1cb8e87b8094 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.17e-04 | 163 | 130 | 5 | 51dee6c21cbeca4e17d1cc386e203f0c403089e8 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 163 | 130 | 5 | 30cd95d4f37bd54c1fde54960cb005db58bdd30c | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 163 | 130 | 5 | ab934cb986495adfc8dbe5a276577f2a8fb6ee03 | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 164 | 130 | 5 | d57faa4fce1f1e9a92aaf5cb920af99323252e4b | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 164 | 130 | 5 | d0b6c29e61d15f4dbe4c1f6e5ed3e10f41f820ab | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 164 | 130 | 5 | 718cc64b7ef7d03d095be4b2b54c449154da568c | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.23e-04 | 165 | 130 | 5 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 167 | 130 | 5 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | Control-Epithelial_alveolar-Mes-like|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-04 | 168 | 130 | 5 | 3c2ce9cfaca8ceab9b29f918ab46afc69eba3330 | |
| ToppCell | ASK428-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.34e-04 | 168 | 130 | 5 | c399fcb4d1d0be48026c2ecabc34a5935e7adf73 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-intermediate_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-04 | 168 | 130 | 5 | 00cff4698db14e03ca1d1b409e5ed1ad23b12615 | |
| ToppCell | Control-Epithelial_alveolar-Mes-like-AT1_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-04 | 168 | 130 | 5 | 49180994311b3f4f9ec338b1d35d8edd7422e3c9 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 169 | 130 | 5 | 05b138511039f1255a5f647040b1b9bdf222bd52 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-04 | 169 | 130 | 5 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-04 | 169 | 130 | 5 | 90c00ab30e582b0e2a2be751e1fae9024cfb9ea6 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 169 | 130 | 5 | bf0a97f53d6e3f9ffeaeae0402b010c49a6cccb7 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.38e-04 | 169 | 130 | 5 | 50cc0f5a022b95986949db63208a627cef9f4a69 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.42e-04 | 170 | 130 | 5 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | droplet-Fat-Scat|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 170 | 130 | 5 | de722bea7527d6ad11b69f8e9589638f52854beb | |
| Computational | Genes in the cancer module 80. | 1.11e-04 | 32 | 85 | 4 | MODULE_80 | |
| Computational | Genes in the cancer module 51. | 1.77e-04 | 36 | 85 | 4 | MODULE_51 | |
| Drug | Rgd Peptide | 1.03e-06 | 239 | 128 | 10 | CID000104802 | |
| Drug | Metaraminol bitartrate [33402-03-8]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.70e-06 | 196 | 128 | 9 | 2298_DN | |
| Drug | AC1L1IPV | 4.21e-06 | 43 | 128 | 5 | CID000004683 | |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; HL60; HG-U133A | 1.44e-05 | 194 | 128 | 8 | 2009_DN | |
| Drug | H-7 dihydrochloride; Up 200; 100uM; PC3; HT_HG-U133A | 1.49e-05 | 195 | 128 | 8 | 5941_UP | |
| Drug | trichostatin A; Up 200; 0.1uM; ssMCF7; HG-U133A | 1.55e-05 | 196 | 128 | 8 | 413_UP | |
| Drug | Riboflavine [83-88-5]; Down 200; 10.6uM; HL60; HG-U133A | 1.55e-05 | 196 | 128 | 8 | 1767_DN | |
| Drug | Propafenone hydrochloride [34183-22-7]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.61e-05 | 197 | 128 | 8 | 2871_DN | |
| Drug | Flecainide acetate [54143-56-5]; Down 200; 8.4uM; HL60; HT_HG-U133A | 1.61e-05 | 197 | 128 | 8 | 2557_DN | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 1.61e-05 | 197 | 128 | 8 | 6240_DN | |
| Drug | Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; HL60; HT_HG-U133A | 1.67e-05 | 198 | 128 | 8 | 1330_UP | |
| Drug | Articaine hydrochloride [23964-57-0]; Up 200; 12.4uM; PC3; HT_HG-U133A | 1.73e-05 | 199 | 128 | 8 | 7272_UP | |
| Drug | vandetanib | 2.05e-05 | 99 | 128 | 6 | CID003081361 | |
| Drug | agathisflavone | 3.14e-05 | 2 | 128 | 2 | CID005281599 | |
| Drug | ponatinib | 4.08e-05 | 68 | 128 | 5 | ctd:C545373 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 6.77e-05 | 178 | 128 | 7 | 5065_UP | |
| Drug | Tocotrienols | 9.37e-05 | 3 | 128 | 2 | ctd:D024508 | |
| Drug | sunitinib | 9.47e-05 | 130 | 128 | 6 | CID005329102 | |
| Drug | Hexetidine [141-94-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.09e-04 | 192 | 128 | 7 | 3318_DN | |
| Drug | nickel hydroxide | 1.11e-04 | 259 | 128 | 8 | CID000025500 | |
| Drug | tetramethylammonium chloride | 1.11e-04 | 17 | 128 | 3 | CID000006379 | |
| Drug | 5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA | 1.12e-04 | 193 | 128 | 7 | 950_UP | |
| Drug | CP-863187 [668981-07-5]; Down 200; 10uM; PC3; HT_HG-U133A | 1.16e-04 | 194 | 128 | 7 | 7558_DN | |
| Drug | Tribenoside [10310-32-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.16e-04 | 194 | 128 | 7 | 3507_UP | |
| Drug | estradiol, USP; Up 200; 0.01uM; ssMCF7; HG-U133A | 1.24e-04 | 196 | 128 | 7 | 414_UP | |
| Drug | Aminocaproic acid [60-32-2]; Up 200; 30.4uM; HL60; HT_HG-U133A | 1.24e-04 | 196 | 128 | 7 | 3122_UP | |
| Drug | Ethamsylate [2624-44-4]; Up 200; 15.2uM; HL60; HT_HG-U133A | 1.24e-04 | 196 | 128 | 7 | 2915_UP | |
| Drug | 6-Hydroxytropinone [5932-53-6]; Down 200; 25.8uM; MCF7; HT_HG-U133A | 1.24e-04 | 196 | 128 | 7 | 7346_DN | |
| Drug | AH6809; Down 200; 1uM; PC3; HT_HG-U133A | 1.24e-04 | 196 | 128 | 7 | 7049_DN | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A | 1.28e-04 | 197 | 128 | 7 | 4461_DN | |
| Drug | N-Acetyl-L-leucine [1188-21-2]; Up 200; 23uM; HL60; HT_HG-U133A | 1.28e-04 | 197 | 128 | 7 | 3085_UP | |
| Drug | Salbutamol [18559-94-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A | 1.28e-04 | 197 | 128 | 7 | 2306_DN | |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 1.28e-04 | 197 | 128 | 7 | 7504_DN | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.28e-04 | 197 | 128 | 7 | 3618_DN | |
| Drug | Beta-sistosterol [83-46-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.28e-04 | 197 | 128 | 7 | 7332_DN | |
| Drug | SC-58125; Up 200; 10uM; HL60; HG-U133A | 1.28e-04 | 197 | 128 | 7 | 542_UP | |
| Drug | Ondansetron Hydrochloride [103639-04-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.28e-04 | 197 | 128 | 7 | 3575_DN | |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Up 200; 12.4uM; HL60; HT_HG-U133A | 1.28e-04 | 197 | 128 | 7 | 2404_UP | |
| Drug | Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.28e-04 | 197 | 128 | 7 | 3455_DN | |
| Drug | C75; Up 200; 10uM; PC3; HT_HG-U133A | 1.28e-04 | 197 | 128 | 7 | 6399_UP | |
| Drug | Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; PC3; HT_HG-U133A | 1.28e-04 | 197 | 128 | 7 | 5735_DN | |
| Drug | Tropicamide [1508-75-4]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.28e-04 | 197 | 128 | 7 | 2309_DN | |
| Drug | Diperodon hydrochloride [537-12-2]; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.32e-04 | 198 | 128 | 7 | 4498_DN | |
| Drug | Biotin [58-85-5]; Down 200; 16.4uM; HL60; HT_HG-U133A | 1.32e-04 | 198 | 128 | 7 | 2428_DN | |
| Drug | Ifenprodil tartrate [23210-58-4]; Up 200; 8.4uM; HL60; HT_HG-U133A | 1.32e-04 | 198 | 128 | 7 | 2372_UP | |
| Drug | Disulfiram [97-77-8]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.32e-04 | 198 | 128 | 7 | 5729_DN | |
| Drug | STOCK1N-28457; Down 200; 20uM; PC3; HT_HG-U133A | 1.32e-04 | 198 | 128 | 7 | 6864_DN | |
| Drug | estradiol, USP; Up 200; 0.1uM; PC3; HT_HG-U133A | 1.32e-04 | 198 | 128 | 7 | 1208_UP | |
| Drug | Quinidine hydrochloride monohydrate [6151-40-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 1.32e-04 | 198 | 128 | 7 | 5793_DN | |
| Drug | Betonicine [515-25-3]; Down 200; 25.2uM; PC3; HT_HG-U133A | 1.32e-04 | 198 | 128 | 7 | 3745_DN | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.32e-04 | 198 | 128 | 7 | 5325_DN | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.36e-04 | 199 | 128 | 7 | 3531_DN | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.36e-04 | 199 | 128 | 7 | 2807_DN | |
| Drug | Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.36e-04 | 199 | 128 | 7 | 6624_DN | |
| Drug | Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; HL60; HT_HG-U133A | 1.40e-04 | 200 | 128 | 7 | 3078_DN | |
| Drug | 3-pentanone | 1.57e-04 | 19 | 128 | 3 | CID000007288 | |
| Disease | myocardial infarction | ARHGAP42 FN1 PSG1 NBEAL1 BCAR1 PDLIM5 B9D2 SMARCA4 NOS3 YTHDF3 | 2.77e-06 | 350 | 126 | 10 | EFO_0000612 |
| Disease | Colorectal Carcinoma | FN1 POLE FPGS GATA4 ABCB6 RET PTPRD SACS TP63 TENM1 SPAG17 DCLK1 ZMYM4 | 1.02e-05 | 702 | 126 | 13 | C0009402 |
| Disease | Malignant neoplasm of breast | EPHB4 FN1 ACHE ABCB6 BCAR1 COG3 EZH2 SLC2A2 HNRNPK CRX PTPRD TAX1BP1 TENM1 GPC2 DNAH9 NOS3 | 1.42e-05 | 1074 | 126 | 16 | C0006142 |
| Disease | aspirin use measurement | 2.32e-05 | 39 | 126 | 4 | EFO_0007013 | |
| Disease | Colorectal Neoplasms | 2.63e-05 | 277 | 126 | 8 | C0009404 | |
| Disease | cD177 antigen measurement | 5.92e-05 | 18 | 126 | 3 | EFO_0021866 | |
| Disease | Antithrombotic agent use measurement | 9.13e-05 | 55 | 126 | 4 | EFO_0009925 | |
| Disease | urinary bladder cancer (is_marker_for) | 9.84e-05 | 107 | 126 | 5 | DOID:11054 (is_marker_for) | |
| Disease | Coloboma of lens | 1.08e-04 | 4 | 126 | 2 | C0344516 | |
| Disease | Coloboma of eyelid | 1.08e-04 | 4 | 126 | 2 | C0521573 | |
| Disease | Congenital coloboma of iris | 1.79e-04 | 5 | 126 | 2 | C0266551 | |
| Disease | Abnormality of the cerebellum | 1.79e-04 | 5 | 126 | 2 | C1866129 | |
| Disease | Coloboma of optic disc | 1.79e-04 | 5 | 126 | 2 | C0155299 | |
| Disease | Coloboma of choroid and retina | 1.79e-04 | 5 | 126 | 2 | C4708599 | |
| Disease | Hereditary macular coloboma | 1.79e-04 | 5 | 126 | 2 | C1852767 | |
| Disease | glucose measurement | 2.36e-04 | 380 | 126 | 8 | EFO_0004468 | |
| Disease | ficolin-1 measurement | 2.68e-04 | 6 | 126 | 2 | EFO_0008134 | |
| Disease | white matter hyperintensity measurement | 3.28e-04 | 302 | 126 | 7 | EFO_0005665 | |
| Disease | urate measurement, bone density | RHCG TTC28 TNFSF9 TENM2 PTPRD MAP4K5 SEC16A OLFM1 DNAH9 DCLK1 | 3.35e-04 | 619 | 126 | 10 | EFO_0003923, EFO_0004531 |
| Disease | chronic kidney disease | 5.32e-04 | 235 | 126 | 6 | EFO_0003884 | |
| Disease | renovascular hypertension (implicated_via_orthology) | 6.39e-04 | 9 | 126 | 2 | DOID:1591 (implicated_via_orthology) | |
| Disease | ciliopathy (implicated_via_orthology) | 6.69e-04 | 40 | 126 | 3 | DOID:0060340 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 6.90e-04 | 447 | 126 | 8 | C3714756 | |
| Disease | Gastric Adenocarcinoma | 9.46e-04 | 45 | 126 | 3 | C0278701 | |
| Disease | atopic eczema, childhood onset asthma, atopic march | 9.70e-04 | 11 | 126 | 2 | EFO_0000274, EFO_0007755, MONDO_0005405 | |
| Disease | endometrial carcinoma, endometriosis | 9.70e-04 | 11 | 126 | 2 | EFO_0001065, EFO_1001512 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 1.16e-03 | 12 | 126 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 1.21e-03 | 49 | 126 | 3 | EFO_0022256 | |
| Disease | parental longevity | 1.31e-03 | 494 | 126 | 8 | EFO_0007796 | |
| Disease | coronary artery disease, factor VII measurement | 1.33e-03 | 111 | 126 | 4 | EFO_0001645, EFO_0004619 | |
| Disease | phosphocreatine measurement | 1.37e-03 | 13 | 126 | 2 | EFO_0010521 | |
| Disease | Small cell carcinoma of lung | 1.61e-03 | 54 | 126 | 3 | C0149925 | |
| Disease | creatinine measurement, glomerular filtration rate | 1.62e-03 | 117 | 126 | 4 | EFO_0004518, EFO_0005208 | |
| Disease | sex interaction measurement, inflammatory bowel disease | 1.70e-03 | 55 | 126 | 3 | EFO_0003767, EFO_0008343 | |
| Disease | Opioid use measurement | 1.83e-03 | 15 | 126 | 2 | EFO_0009937 | |
| Disease | African Burkitt's lymphoma | 1.83e-03 | 15 | 126 | 2 | C0343640 | |
| Disease | Carcinoma of Endocrine Gland | 1.83e-03 | 15 | 126 | 2 | C1704374 | |
| Disease | Burkitt Leukemia | 1.83e-03 | 15 | 126 | 2 | C4721444 | |
| Disease | Mammary Carcinoma, Human | 1.92e-03 | 525 | 126 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.92e-03 | 525 | 126 | 8 | C1257931 | |
| Disease | Mammary Neoplasms | 1.96e-03 | 527 | 126 | 8 | C1458155 | |
| Disease | low density lipoprotein particle size measurement | 1.98e-03 | 58 | 126 | 3 | EFO_0008593 | |
| Disease | C-reactive protein measurement | IL12RB1 GATA4 SLC6A15 AIP SLC2A2 PACS1 MAP4K5 DNAH17 SEC16A SMARCA4 MAP4K4 ALPL PSD4 | 1.98e-03 | 1206 | 126 | 13 | EFO_0004458 |
| Disease | central nervous system disease (implicated_via_orthology) | 2.09e-03 | 16 | 126 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | hip bone mineral density | 2.12e-03 | 126 | 126 | 4 | EFO_0007702 | |
| Disease | Breast Carcinoma | 2.23e-03 | 538 | 126 | 8 | C0678222 | |
| Disease | free cholesterol in very large HDL measurement | 2.39e-03 | 62 | 126 | 3 | EFO_0022273 | |
| Disease | Alzheimer's disease (is_implicated_in) | 2.51e-03 | 132 | 126 | 4 | DOID:10652 (is_implicated_in) | |
| Disease | pulse pressure measurement | ARHGAP42 EPHB4 FN1 TTC28 PSG1 NBEAL1 BCAR1 ARHGEF25 PDLIM5 B9D2 PTPRD SLC38A7 FGR KDM4B | 2.52e-03 | 1392 | 126 | 14 | EFO_0005763 |
| Disease | Global developmental delay | 2.58e-03 | 133 | 126 | 4 | C0557874 | |
| Disease | energy intake | 2.65e-03 | 134 | 126 | 4 | EFO_0003939 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 2.95e-03 | 19 | 126 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | breast size | 3.24e-03 | 69 | 126 | 3 | EFO_0004884 | |
| Disease | IgA glomerulonephritis (is_marker_for) | 3.27e-03 | 20 | 126 | 2 | DOID:2986 (is_marker_for) | |
| Disease | asthma, age at onset | 3.38e-03 | 70 | 126 | 3 | EFO_0004847, MONDO_0004979 | |
| Disease | fumarate measurement | 3.60e-03 | 21 | 126 | 2 | EFO_0010480 | |
| Disease | Endometrial Carcinoma | 3.66e-03 | 72 | 126 | 3 | C0476089 | |
| Disease | stomach cancer (is_implicated_in) | 3.66e-03 | 72 | 126 | 3 | DOID:10534 (is_implicated_in) | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.69e-03 | 239 | 126 | 5 | EFO_0008317, EFO_0020945 | |
| Disease | lung cancer (is_implicated_in) | 3.95e-03 | 74 | 126 | 3 | DOID:1324 (is_implicated_in) | |
| Disease | gait measurement | 3.97e-03 | 150 | 126 | 4 | EFO_0007680 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QYMSWPDRGVPSSPD | 191 | Q99952 | |
| EPYSSWIPQEMAAAG | 71 | Q13075 | |
| TLYPGFEGTEMWNPN | 106 | P22303 | |
| TQWPRSADEPGLYMA | 291 | O60241 | |
| EDWSVYPGPSSTMGT | 81 | O14627 | |
| PMPAGAAVANYTNWA | 91 | Q902F8 | |
| PMPAGAAAANYTNWA | 91 | Q9UKH3 | |
| DSGQAGPYENWMLEP | 96 | Q86VW2 | |
| GPYENWMLEPALATG | 101 | Q86VW2 | |
| AMDPQASDWSPQESG | 566 | A6NC98 | |
| IYQVPPSMDTRSWEG | 191 | P56945 | |
| VQRSGPQYMWDPDTL | 411 | Q96QA5 | |
| IMAFPPEKYAQWSAG | 196 | P50052 | |
| YQWPSPEAGIELMRD | 161 | Q8N4X5 | |
| YKASPDLVPMGEWTA | 176 | O95782 | |
| FDLVDDYPSLPSMGW | 121 | P53672 | |
| DYPSLPSMGWASKDV | 126 | P53672 | |
| NYCEAEGPVGPAWMQ | 6 | Q9NP58 | |
| MWISKPEYDEAGPSI | 356 | P63267 | |
| PNAFETDSDLPAGWM | 246 | O00213 | |
| SAPASWDFGVPQRMA | 236 | Q07687 | |
| MDPYSAIPTSTWEEQ | 41 | A0A1B0GTU2 | |
| YQEIWTSLGSAMPEP | 456 | O75071 | |
| KVESPGTYQQDPWAM | 156 | O00170 | |
| YRTSPDLVPMGDWTS | 176 | O94973 | |
| SIPATWQALMDNPYD | 2136 | Q6ZS30 | |
| QVPGSEPDMSQYWPR | 406 | P26367 | |
| EMSPWVIGTNYTLYP | 306 | Q9Y4B6 | |
| NTFIGTPYWMAPEVI | 186 | O95819 | |
| EDNLGPLPENWEMAY | 296 | Q96QZ7 | |
| PLPENWEMAYTENGE | 301 | Q96QZ7 | |
| MGQYEFPNPEWSEVS | 281 | P49137 | |
| PYSLPQGFMWDTLDL | 151 | O60551 | |
| VTGGWVMPDEATPHY | 246 | Q16706 | |
| DTATALTPAWMENPY | 121 | P54760 | |
| PGCPASLYEAMEQTW | 481 | P09769 | |
| QQYADDWMAGAVAPP | 506 | Q8N158 | |
| YSFTGEWIQPPEEML | 186 | Q5MY95 | |
| MIPADAPAQWRAESY | 451 | Q5MY95 | |
| ILMGQVDFPSPYWDN | 601 | O15075 | |
| PPENVEWSGAEASMF | 426 | Q15910 | |
| FGSWMTDPLAPEGDN | 246 | Q99784 | |
| TDPLAPEGDNRVWYM | 251 | Q99784 | |
| QASSPPDYTMAWAEY | 536 | Q96I24 | |
| SYSMNPKPTPWAEEE | 71 | P11168 | |
| AGVLMEPDDWPYVVS | 886 | O94953 | |
| VASASSPFWMENPYV | 141 | P54753 | |
| YPDFPTSPGSWLDEM | 371 | Q969G2 | |
| EEMDIGPYMDTPNWS | 151 | Q96RT8 | |
| GPYMDTPNWSEESEE | 156 | Q96RT8 | |
| YSSAGWSEPSDPLEM | 101 | O75022 | |
| AAGAVEWMYPTGALI | 76 | Q641Q3 | |
| LSMEYPAQLWPDASA | 56 | Q2VPB7 | |
| PTIMVTYNGDFFDWP | 356 | Q07864 | |
| MSNYSVSLVGPAPWG | 1 | Q96HC4 | |
| EDVDFLPYMSWQGEP | 1201 | Q9UKK3 | |
| PMNLFATWEVDGSSP | 21 | Q86VP3 | |
| SWDEGYSTLSIPPEM | 831 | Q3BBV0 | |
| PAPVQMNLYATWEVD | 96 | Q6VY07 | |
| PVAMFSWYLDNTPTE | 691 | Q7Z442 | |
| LEFPAAPFSGWYMST | 346 | P29474 | |
| PWSYPRQAESDMSKP | 136 | Q8TB68 | |
| WYSDNEMPPEALSQG | 186 | P05186 | |
| PEGYMFIWNGEVSPN | 481 | O95302 | |
| PITANNYPISDMEAW | 306 | Q8IUM7 | |
| SDLSDPMWPQYTNLG | 101 | Q9H3D4 | |
| PYPAYMADVGASWAA | 161 | P43694 | |
| FMNEQGEYPPGTSTW | 81 | Q9UIV1 | |
| DTVPDTWVARAYPSM | 4276 | Q9UFH2 | |
| IAGAPVTVWMAYDTG | 751 | Q86TI2 | |
| MWTPPESAVTGYRVD | 926 | P02751 | |
| PQTTISPADLHGMWY | 541 | Q96JB2 | |
| PDPAGMATYSWSRES | 391 | P42701 | |
| LVLSWYPPGMADDNG | 186 | Q5VSG8 | |
| ATGYFPEPVMVTWDT | 31 | P01854 | |
| GLSAWPVPQEPSMEY | 31 | Q05932 | |
| TPPWMIQDEEYIAGN | 241 | Q86UT8 | |
| QTTWAGMEFQYEPHP | 1441 | Q9NYC9 | |
| YGDEVPGPEMENAWN | 1426 | Q5TBA9 | |
| PRWTPDDYINMTSDC | 86 | Q02742 | |
| VDTPQIGDMAYWSHP | 46 | Q9BPU9 | |
| PETPDASYLWWMNGQ | 171 | Q9UQ72 | |
| ETLWSKDMAPYQGPA | 141 | Q9NZJ4 | |
| DPTGTWKFTYNPMDP | 271 | O43186 | |
| PETPDASYLWWMNGQ | 171 | P11464 | |
| IGTPYWMAPEVAAVE | 176 | Q9Y4K4 | |
| PETPDASYLWWMNGQ | 171 | Q16557 | |
| LSWEIPENYNSAMPF | 1036 | P23468 | |
| PSEYTWFKDGIVMPT | 161 | Q9Y624 | |
| NTFIGTPYWMAPEVI | 186 | Q8N4C8 | |
| SEFPDPMWGSDYVQL | 571 | Q9Y6R4 | |
| SFIGTPYWMAPEVAA | 171 | Q92918 | |
| SFIGTPYWMAPEVID | 211 | Q7Z2Y5 | |
| NMGLSPPGYNAWIED | 591 | Q9H2J7 | |
| FLWSPMPEHYVEGST | 66 | Q86VP1 | |
| KTDAPSGMELQSWYP | 366 | P12757 | |
| SPFNTAVADYWMPVD | 541 | Q15031 | |
| SDEPQSASPSPSYMW | 311 | Q5JRV8 | |
| GYAEDPMASQPLPDW | 1836 | O14513 | |
| WDEGYSTLSIPPEML | 561 | Q6P3W6 | |
| WDEGYSTLSIPPEML | 221 | Q5TI25 | |
| WDEGYSTLSIPPEML | 221 | B4DH59 | |
| ANQDYRPPSQWTMEG | 256 | A6NI28 | |
| PETPDASYLWWMNGQ | 171 | Q9UQ74 | |
| TWSPSEWQMAYEPQG | 351 | P61978 | |
| SAGYPDFTNPTMRAW | 506 | Q14697 | |
| TAMAIEEYPEAWGSG | 71 | P03923 | |
| PDSSPQWGAEEESMF | 231 | Q8NDX1 | |
| AWLEMNPGYEVAPRS | 641 | P51532 | |
| PRRGWPETYDMNTSE | 1046 | O60292 | |
| MAKEPEGASGPWYTD | 161 | Q9NVC3 | |
| ASPANSFVGTPYWMA | 176 | Q7L7X3 | |
| NSFVGTPYWMAPEVI | 176 | Q9H2K8 | |
| WPTDLAVNPMDNSLY | 1366 | Q9UKZ4 | |
| WPTDLAVNPMDNSLY | 1416 | Q9NT68 | |
| PETPDASYLWWMNGQ | 171 | Q13046 | |
| MYAWGQESGAPILTD | 731 | Q15436 | |
| GSDSEMFNIPWDNPA | 626 | Q6Q759 | |
| AGDPVPNMYWDVGNL | 221 | Q16620 | |
| SFSPGTPMWAALDEQ | 281 | Q9Y3P4 | |
| QYNSSEWMPGEPIYT | 966 | Q8N2E2 | |
| EWMPGEPIYTQTVFH | 971 | Q8N2E2 | |
| WSTAGDQPMPYLTTY | 76 | Q7Z739 | |
| NTFIGTPYWMAPEVI | 186 | Q9UKE5 | |
| DAPSEIWSSYTENPM | 2401 | Q99973 | |
| YGYPADTVWPAMEQV | 1421 | O15027 | |
| DGREIQWPSAMYPDL | 141 | Q12767 | |
| KPYEWNDSGPDFIQM | 231 | Q9NYW8 | |
| AMTPWNQGATPAYGA | 1516 | P24928 | |
| GMEASPGEFPWQASL | 206 | Q7Z410 | |
| MEYASDASLDPEAPW | 1 | P41273 | |
| PNDSVYANWMLSPSA | 1091 | P07949 | |
| WEMPEGNSTVYIPED | 436 | Q9UBD6 | |
| WGPMPSAEEEAYMVS | 1501 | Q96AY4 | |
| NSRPEEPSTWSGYMG | 266 | Q5MNZ9 | |
| VGFPDLMSPSEVYSW | 1371 | A3KMH1 | |
| WYSTFPIDPGTLDTM | 1506 | Q5VZL5 | |
| SFGTNAGSLWPDPME | 211 | A6NCI4 | |
| TAWYSDMETPLKAGP | 261 | Q309B1 | |
| EAWTMPEPGPAYDLT | 806 | P54296 |